Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651823.RAHkr-WipJDUzIX3xIGcmw4xdEcnXsSLRM_tpLqRtah4k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651823.RAHkr-WipJDUzIX3xIGcmw4xdEcnXsSLRM_tpLqRtah4k130_assertion type Assertion NP651823.RAHkr-WipJDUzIX3xIGcmw4xdEcnXsSLRM_tpLqRtah4k130_head.
- NP651823.RAHkr-WipJDUzIX3xIGcmw4xdEcnXsSLRM_tpLqRtah4k130_assertion description "[Patients with ALK gene rearrangements (OR = 5.50; 95% CI = 1.76, 17.18; P = .003) and patients with EGFR mutations (OR = 5.17; 95% CI = 1.63, 16.43; P = .006) were predisposed to liver metastasis compared to the triple negative cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651823.RAHkr-WipJDUzIX3xIGcmw4xdEcnXsSLRM_tpLqRtah4k130_provenance.
- NP651823.RAHkr-WipJDUzIX3xIGcmw4xdEcnXsSLRM_tpLqRtah4k130_assertion evidence source_evidence_literature NP651823.RAHkr-WipJDUzIX3xIGcmw4xdEcnXsSLRM_tpLqRtah4k130_provenance.
- NP651823.RAHkr-WipJDUzIX3xIGcmw4xdEcnXsSLRM_tpLqRtah4k130_assertion SIO_000772 22282022 NP651823.RAHkr-WipJDUzIX3xIGcmw4xdEcnXsSLRM_tpLqRtah4k130_provenance.
- NP651823.RAHkr-WipJDUzIX3xIGcmw4xdEcnXsSLRM_tpLqRtah4k130_assertion wasDerivedFrom befree-20140225 NP651823.RAHkr-WipJDUzIX3xIGcmw4xdEcnXsSLRM_tpLqRtah4k130_provenance.
- NP651823.RAHkr-WipJDUzIX3xIGcmw4xdEcnXsSLRM_tpLqRtah4k130_assertion wasGeneratedBy ECO_0000203 NP651823.RAHkr-WipJDUzIX3xIGcmw4xdEcnXsSLRM_tpLqRtah4k130_provenance.